To assess the possible contribution of host immune responses to the exertion of Fv2 -associated resistance to Friend virus (FV)-induced disease development, we inoculated C57BL/6 (B6) mice that lacked various subsets of lymphocytes with FV containing no lactate dehydrogenase-elevating virus. Fv2r B6 mice lacking CD4 + T cells developed early polycythemia and fatal erythroleukemia, while B6 mice lacking CD8 + T cells remained resistant. Erythroid progenitor cells infected with spleen focus-forming virus (SFFV) were eliminated, and no polycythemia was observed in B cell-deficient B6 mice, but they later developed myeloid leukemia associated with oligoclonal integration of ecotropic Friend murine leukemia virus. Additional depletion of natural killer and/or CD8 + T cells from B cell-deficient B6 mice resulted in the expansion of SFFV proviruses and the development of polycythemia, indicating that SFFV-infected erythroid cells are not only restricted in their growth but are actively eliminated in Fv2r mice through cellular immune responses.
Tissue and subcellular localization and its changes upon cell activation of virus-restricting APOBEC3 at protein levels are important to understanding physiological functions of this cytidine deaminase, but have not been thoroughly analyzed in vivo. To precisely follow the possible activation-induced changes in expression levels of APOBEC3 protein in different mouse tissues and cell populations, genome editing was utilized to establish knock-in mice that express APOBEC3 protein with an in-frame FLAG tag. Flow cytometry and immunohistochemical analyses were performed prior to and after an immunological stimulation. Cultured B cells expressed higher levels of APOBEC3 protein than T cells. All differentiation and activation stages of freshly prepared B cells expressed significant levels of APOBEC3 protein, but germinal center cells possessed the highest levels of APOBEC3 protein localized in their cytoplasm. Upon immunological stimulation with sheep red blood cells in vivo, germinal center cells with high levels of APOBEC3 protein expression increased in their number, but FLAG-specific fluorescence intensity in each cell did not change. T cells, even those in germinal centers, did not express significant levels of APOBEC3 protein. Thus, mouse APOBEC3 protein is expressed at distinctively high levels in germinal center B cells. Antigenic stimulation did not affect expression levels of cellular APOBEC3 protein despite increased numbers of germinal center cells.
28 September 2026 in Frontiers in Veterinary Science
Canine prostatic carcinoma is a highly aggressive malignancy with a poor prognosis and limited long-term treatment options. Prostatic artery embolization (PAE) has emerged as a minimally invasive alternative, but long-term intraprostatic imaging changes after PAE in dogs remain poorly documented. We performed PAE on a 13-year-old neutered male Chihuahua with prostatic carcinoma. Designating PAE as Day 0, we monitored the prostate, bladder, and lungs with computed tomography (CT), ultrasonography (US), and thoracic radiography for approximately 900 days. Clinical signs remained well controlled; the dog survived until Day 918. CT showed intraprostatic hypoattenuating lesions (Day 33) that enlarged with gas accumulation (Day 173); US showed hypoechoic lesions (Day 271) that became scattered hyperechoic foci (Day 678). Following PAE, the prostatic parenchymal volume decreased by approximately 33% and remained stable until Day 481. No serious PAE-related complications were observed. These findings suggest that PAE induced sustained ischemic, cavitary, and chronic remodeling changes within the prostate, which may have contributed to the prolonged local disease control observed in this dog. To our knowledge, this represents the longest time-course imaging reported after PAE in a dog with prostatic carcinoma and illustrates the potential of PAE as a feasible, minimally invasive treatment option in general veterinary practice.